Evidence map›Paper›PMID 39516717›Full record

ArticleBMC microbiology2024

Surface-functionalized UIO-66-NH

Nazanin Rahmanian, Pooria Moulavi, Fatemeh Ashrafi, Aram Sharifi, Sepideh Asadi

Abstract read
In one paragraph

Article in BMC microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Hierarchical Functionalisation of UiO-66(Zr)-NHNanomaterials (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Eco-friendly synthesis of copper nanoparticles by usingBiochemistry and biophysics reports · 2025
    Article
  8. Impact of oleuropein onIranian journal of microbiology · 2025
    Article
  9. Green-synthesized α-FeBMC microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nazanin RahmanianFaculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Pooria MoulaviDepartment of Biology, North Tehran Branch, Islamic Azad University, Tehran, Iran.
Fatemeh AshrafiDepartment of Biology, North Tehran Branch, Islamic Azad University, Tehran, Iran.
Aram SharifiDepartment of Animal Science, Faculty of Agriculture, University of Kurdistan, Sanandaj, Kurdistan, Iran.
Sepideh AsadiDepartment of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran. sepidehasadi1394@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundConventional antibacterial compounds can inhibit the growth of microorganisms, but their adverse effects and the development of drug limit their widespread use. The current study aimed to synthesize PEG-coated UIO-66-NH

methodsThe VAN/AMK-UIO-66-NH

resultsAs demonstrated by MIC, MBC and time-kill assay, the VAN/AMK-UIO-66-NH

conclusionsThese findings highlighted the efficiency of VAN/AMK-UIO-66@NH

Indexed as

AmikacinAnti-Bacterial AgentsBiofilmsMicrobial Sensitivity TestsNanoparticlesVancomycinVancomycin-Resistant Staphylococcus aureusDrug CarriersDrug Delivery SystemsDrug LiberationHumansPolyethylene GlycolsStaphylococcal InfectionsAmikacinAnti-Bacterial AgentsDrug CarriersPolyethylene GlycolsVancomycinAmikacinBiofilmsMetal-Organic frameworksVancomycinVancomycin-resistant S. Aureus

Identifiers

PMID39516717
PMCPMC11546402

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.